BS Identity and Score for Gilead Sciences (ZYDELIG)

AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: Gilead Sciences (ZYDELIG) (zydelig.com)

https://zydelig.com 📍 Industry: Medical Devices, Pharma & Biotech
11 BS / 100

This is a benchmark for low-BS medical communication. It prioritizes clinical transparency and regulatory safety requirements over marketing narrative. The presence of specific, cited percentages and months of survival data provides absolute substance.

Info Density Power-words vs. Substance ratio.
6
20% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
1
5% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
1
5% BS
Commodity Fingerprint Detection of industry clichés/templates.
3
20% BS
Identity & Authority Expert verifiability & Schema depth.
0
0% BS

Consolidate the duplicate H2 ‘What is ZYDELIG?’ on the homepage to improve heading hierarchy. Provide direct outbound links to the peer-reviewed publications cited in the footnotes to facilitate faster clinician verification. Update the patient resources section to include the original publication dates of the external advocacy tips to ensure temporal relevance.

Info Density Power-words vs. Substance ratio.
6 Impact Weight: 30 / 100
20% BS

Information density is exceptionally high for a public-facing website. The About ZYDELIG page provides specific clinical metrics, including a 19.4-month progression-free survival rate versus a 6.5-month control and an 84 percent response rate. This substance-to-fluff ratio is far superior to typical corporate marketing sites, with marketing language largely confined to standard navigation labels.

When chunking fails, embeddings degrade, retrieval collapses, and your content loses every competitive comparison. Generate your Semantic HTML Audit to quantify the structural friction that blocks AI comprehension.

Semantic Coherence Homepage promise vs. Sub-page reality.
1 Impact Weight: 20 / 100
5% BS

Semantic drift is nearly zero. The homepage H1 ‘support your journey’ is a standard patient-centric entry point, but it immediately aligns with technical dosing and side-effect management on sub-pages. There is no disconnect between the patient-friendly introduction and the specific clinical data delivered in the About Zydelig and HCP sections.

Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.

Trust & Proof Verifiable evidence vs. Trust Theatre.
1 Impact Weight: 20 / 100
5% BS

The site avoids trust theatre entirely. It has a review_count of 0 and relies instead on high-quality external validation, including FDA-regulated prescribing information and ClinicalTrials.gov study parameters. It prominently features mandatory boxed warnings for fatal toxicities, which represents the highest form of regulatory substance over marketing bullshit.

Proof density is very high across the analyzed pages. Almost every therapeutic claim is superscripted with a citation (1-5) referencing specific clinical studies. The side-effects management page even includes specific percentages (67 percent) regarding the success of dose modifications in clinical trials.

For a high volume editorial domain example, open the Search Engine Journal Semantic HTML audit. View the SEJ Semantic HTML Audit to see how template drift and structural noise impact AI chunking.

Commodity Fingerprint Detection of industry clichés/templates.
3 Impact Weight: 15 / 100
20% BS

While the site uses standard pharma fingerprints like ‘Patient Resources’ and ‘For Healthcare Professionals,’ it fills these templates with granular substance. The clinical data provided (e.g., specific 66 percent disease-free progression at 1 year) is unique to the product and cannot be copy-pasted onto a competitor’s drug.

Identity & Authority Expert verifiability & Schema depth.
0 Impact Weight: 15 / 100
0% BS

There are no authority gaps. The site is explicitly branded by Gilead and cites the U.S. Food and Drug Administration (FDA) as the recognizing authority in the schema_json. It correctly uses MedicalWebPage schema to define its audience (Patient and Clinician) and specialty (Oncologic), matching its content perfectly.

There is no disconnect between claims and evidence. Performance claims like ‘Proven effective in relapsed CLL’ are immediately followed by clinical trial parameters (n=220) and specific statistical outcomes. This is a data-led technical communication that satisfies even the strictest forensic proof requirements.

Medical Devices, Pharma & Biotech BS: Gilead Sciences (ZYDELIG) (zydelig.com)

BS: 11/ 100

The site perfectly matches the Pharma & Biotech category, functioning as a regulated product information portal. It contains mandatory safety disclosures, FDA-regulated indications, and clinical trial results characteristic of a prescription drug website.

Every retrieval failure begins with one root cause: the model cannot segment the page correctly. Read the Semantic HTML Technical Guide to learn how structural clarity prevents chunk collapse and embedding noise.

“The extremely low score of 11 is driven by high Information Density and nearly perfect Semantic Coherence. The site relies entirely on verifiable clinical data rather than trust theatre, and its technical schema is robustly implemented with zero identity gaps.”

To understand and learn thinking like AI, visit our educational environment (Gilead Sciences (ZYDELIG) example) that uses the same data this audit was generated from, and try it yourself.
Verified Analysis Date: May 26, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Get a Strategic Holistic View
FREE TOOLS
BUSINESS STRATEGY

Business Intelligence Engine

×
AI VISIBILITY